| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/27/2010 | CN100584846C Dealkylated derivatives of pyrrolo[2,1-b]benzothiazepines with atypical antipsychotic activity |
| 01/27/2010 | CN100584844C Imidazo 1,2-c pyrimidinylacetic acid derivatives |
| 01/27/2010 | CN100584843C Substituted diaza-spiro-[5.5|-undecane derivatives and their use as neurokinin antagonists |
| 01/27/2010 | CN100584842C Thiazole derivative |
| 01/27/2010 | CN100584841C Andrographolide derivatives and application of the same in pharmacy |
| 01/27/2010 | CN100584840C Substituted heterocyclic compounds and uses thereof |
| 01/27/2010 | CN100584838C Eremophilone lactones acid natural product and application thereof |
| 01/27/2010 | CN100584837C Hydroxy stilbene kind compound and its preparation method and application |
| 01/27/2010 | CN100584835C Novel medicinal salt for cinepazide and preparation method thereof |
| 01/27/2010 | CN100584832C 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders |
| 01/27/2010 | CN100584831C Pyridazinyl- piperazines and their use as histamine h3 receptor |
| 01/27/2010 | CN100584830C Gabanergic modulators |
| 01/27/2010 | CN100584828C New 5-hydroxy indole-3- carboxylic esters derivative |
| 01/27/2010 | CN100584826C Preparation of r-5-(2-(2-ethoxyphenoxyethylamino)propyl)-2-methoxybenzenesulphonamide hydrochloride of high chemical purity |
| 01/27/2010 | CN100584819C Substituted 4-aminocyclohexanol derivatives |
| 01/27/2010 | CN100584818C Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide |
| 01/27/2010 | CN100584816C Kutkin derivative, preparation method and application thereof |
| 01/27/2010 | CN100584807C Deuterated catecholamine derivatives and medicaments comprising said compounds |
| 01/27/2010 | CN100584385C Tablet and process for producing the same |
| 01/27/2010 | CN100584383C Pharmaceutical composition with Meclofenoxate hydrochloride capable of preventing hydrolysis |
| 01/27/2010 | CN100584382C Medicinal composition containing angiotensin II receptor agonist and fibric acid compound |
| 01/27/2010 | CN100584381C Medicinal composition containing sulfourea antidiabetic medicine and vitamine B |
| 01/27/2010 | CN100584376C Medicine for treating deep erosive trauma with crust |
| 01/27/2010 | CN100584375C Formula for treating scar |
| 01/27/2010 | CN100584372C External use traditional Chinese medicine ointment for treating heart diseases |
| 01/27/2010 | CN100584368C Medicine for treating rheumatoid and rheumatoid arthritis and its preparation method |
| 01/27/2010 | CN100584365C Pharmaceutical composition for treating acne |
| 01/27/2010 | CN100584360C Chinese medicine composition for treating oral inflammation |
| 01/27/2010 | CN100584357C Medicine composition containing borneol and musk |
| 01/27/2010 | CN100584356C Musk containing medicine composition |
| 01/27/2010 | CN100584353C A medicinal composition for treating oral ulcer and its preparation method |
| 01/27/2010 | CN100584349C Chinese traditional western compound medicine and its preparation method |
| 01/27/2010 | CN100584348C Anti-hepatitis medical combination |
| 01/27/2010 | CN100584347C Composition of notoginsen triterpenes and tanshinone IIA sodium sulfonate |
| 01/27/2010 | CN100584345C Distillage of Ardisia chinensis Benth of possessing function of antivirus, extraction method and application |
| 01/27/2010 | CN100584340C Medicament for preventing and controlling stomach diseases |
| 01/27/2010 | CN100584338C Biological activating agent with lead adsorbing and removing functions, its preparation and use |
| 01/27/2010 | CN100584337C Dispersed tablet of tannic matrine and their preparing method |
| 01/27/2010 | CN100584336C Medicinal compositions |
| 01/27/2010 | CN100584335C Composition and uses for treatment of reactive arthritis or bursitis |
| 01/27/2010 | CN100584334C Stabled desogestrel medical combination and the preparing method |
| 01/27/2010 | CN100584333C Pharmaceutical composition of liver disease |
| 01/27/2010 | CN100584332C Eye-drops preparations containing tetrandrine and its application for preparing medicine therewith |
| 01/27/2010 | CN100584331C Use of immunomudulatory compounds in preparing medicine for the treatment, control or prevention of myeloproliferative diseases |
| 01/27/2010 | CN100584330C Substituted benzimidazole proton pump inhibitor composition, and its preparing method |
| 01/27/2010 | CN100584329C Anethol trithione soft capsule and preparation method thereof |
| 01/27/2010 | CN100584328C Use of chlorogenic acid in preparing antihypoxic medicament or foods |
| 01/27/2010 | CN100584327C Medication composition in use for treating liver disease |
| 01/27/2010 | CN100584326C Function of stilbene oxygen acid or salt in preparing antiatheroscloresis medicament |
| 01/27/2010 | CN100584325C Medicine composition containing sodium azulene sulfonate and L-glutamine water-soluble precursor |
| 01/27/2010 | CN100584324C Use of camostat in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) |
| 01/27/2010 | CN100584323C Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders |
| 01/27/2010 | CN100584322C Compositions comprising modafinil compounds |
| 01/27/2010 | CN100584321C Vaginal health products |
| 01/27/2010 | CN100584319C Multiple apertures releasing osmosis pump control release tablet and preparation process thereof |
| 01/27/2010 | CN100584249C Multifunctional cervical vertebra rehabilitation health care pillow with adjustable neck pillow height |
| 01/26/2010 | US7653495 Comprises series of steps including identifying cavity proximal to functional critical site, determining physical parameters of cavity, identifying functional groups which can be accommodated by cavity, testing compounds comprising such functional groups in an in vitro assay to determine which are active |
| 01/26/2010 | US7652161 Zinc-monocysteine complex and method of using zinc-cysteine complexes |
| 01/26/2010 | US7652155 Diamine derivative, production process therefor and antioxidant |
| 01/26/2010 | US7652153 Caspase inhibitors and uses thereof |
| 01/26/2010 | US7652150 [2-(4-Fluoro-]. H-indol-3-ylsulfanyl)benzyl]dimethyl amine; depression, anxiety disorders including general anxiety disorder, social anxiety disorder, post traumatic stress disorder, obsessive compulsive disorder, panic disorder, panic attacks |
| 01/26/2010 | US7652149 Crystalline pyrazoles |
| 01/26/2010 | US7652148 Electrophilic aromatic substitution with diacyl imidazolium |
| 01/26/2010 | US7652144 Compounds as PDE IV and TNF inhibitors |
| 01/26/2010 | US7652143 2-(3-(4-benzyloxybenzyl)-2-oxoimidazolidin-1-yl)-N-hydroxy-3-methylbutyramide; N-hydroxy-3-methyl-2-{2-oxo-3-(4-(pyridin-4-ylmethoxy)benzyl)imidazolidin-1-yl}butyramide with trifluoroacetic acid ; osteoarthrosis and rheumatoid arthritis; TNF- alpha converting enzyme (TACE) inhibitor |
| 01/26/2010 | US7652142 Bipiperidinyl derivatives useful as inhibitors of chemokine receptors |
| 01/26/2010 | US7652139 Clopidogrel salt and polymorphic forms thereof |
| 01/26/2010 | US7652135 Compositions useful as inhibitors of protein kinases |
| 01/26/2010 | US7652130 enhances feel of oil in water emulsions containing polymers as as thickeners, emulsifiers or stabilizers; reacting a branched alkyl Guerbet alcohol having 16 to 28 carbon atoms with xylose; etherification and condensation |
| 01/26/2010 | US7652071 Penetration of active substances into cells and organs |
| 01/26/2010 | US7652069 Polymorphs of suberoylanilide hydroxamic acid |
| 01/26/2010 | US7652068 Omega 3 fatty acid formulations |
| 01/26/2010 | US7652067 Aqueous compositions containing monoester salts |
| 01/26/2010 | US7652066 Compounds having antitumor activity |
| 01/26/2010 | US7652065 Tellurium compounds and their use as immunomodulators |
| 01/26/2010 | US7652064 AMPA receptor potentiators |
| 01/26/2010 | US7652063 For therapy of asthma, dysmenorrhea, osteoporosis, bone disorders, constipation, renal disorders, sexual dysfunction, baldness, acute hepatitis, bronchitis, burn, chronic obstructive respiratory diseases, Crohn's disease, digestive ulcer, hemophagous syndrome, hepatopathy, hypercytokinemia at dialysis |
| 01/26/2010 | US7652062 Cyanopyrrole-phenyl amide progesterone receptor modulators and uses thereof |
| 01/26/2010 | US7652061 (R)-1-{2-[3-(5-Methyl-2-pheny-oxazol-4-ylmethoxy)-phenyl]-acetyl}-pyrrolidine-2-carboxylic acid; dyslipidemia, hyperlipidemia, hypercholesteremia, or type-2 diabetes |
| 01/26/2010 | US7652060 Small molecule rotamase enzyme inhibitors |
| 01/26/2010 | US7652059 1-methyl-4-trifluoromethyl-1H-pyrrole-3-carboxylic acid [2-(1,3-dimethylbutyl)phenyl]amide; protecting plants against infestation by phytopathogenic microorganisms |
| 01/26/2010 | US7652058 Octahydropyrano[3,4-C]pyrrole tachykinin receptor antagonists |
| 01/26/2010 | US7652057 Pyrazolones as 11b-HSD1 inhibitors for diabetes |
| 01/26/2010 | US7652056 Using 4-imidazoline carboxylic acid or ester; antiinflammatory agents; microbiocides; bactericides; antitumor agenst0 |
| 01/26/2010 | US7652055 2-imidazolines |
| 01/26/2010 | US7652054 Gastrointestinal disorders; cardiovascular disorders; dyspepsia;anticancer agents; antiulcer agents |
| 01/26/2010 | US7652053 Diaminocycloalkane MCH receptor antagonists |
| 01/26/2010 | US7652052 Process for producing ramosetron or its salt |
| 01/26/2010 | US7652051 3-amino-benzo[1,2,4]triazine-7-ol-1-oxide; 4-[3-(4-chloro-phenylamino)-benzo[1,2,4]triazin-7-yloxy]-pyridine-2-carboxylic acid methylamide trifluoroacetate salt; modulation of the MAPK pathway; cancer |
| 01/26/2010 | US7652050 Prevention reproduction of fish viruses |
| 01/26/2010 | US7652049 1-benzyl-4-[4'-fluoro-5'-isopropyl-2'-methoxy-4-(trifluoromethyl)biphenyl-2-yl]imidazolidin-2-one; cholesteryl ester transfer protein inhibitor; raising HDL-cholesterol, reducing LDL-cholesterol; atherosclerosis; antiinflammatory agent; synergistic mixture with other active ingredients |
| 01/26/2010 | US7652048 Water-based, antimicrobially active, dispersion concentrates |
| 01/26/2010 | US7652047 Phenylamino isothiazole carboxamidines as MEK inhibitors |
| 01/26/2010 | US7652046 6-phenylsulfanyl-4H-pyrrolo[2,3-d]thiazole-5-carboxylic acid amide; mood disorders; sleep disorders; major depressive disorder; circadian rhythm sleep disorders; jet lag syndrome; bipolar disorders; reaction with diaryldisulfide or diheteroaryldisulfides to give desired compounds |
| 01/26/2010 | US7652045 Activator of peroxisome proliferator-activated receptor δ |
| 01/26/2010 | US7652044 P-38 inhibitors |
| 01/26/2010 | US7652043 Inhibiting aberrant growth states in cells having Wnt receptors; carcinoma |
| 01/26/2010 | US7652042 Compounds that abrogate DNA damage induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments |
| 01/26/2010 | US7652041 Cinnamide and hydrocinnamide derivatives with kinase inhibitory activity |
| 01/26/2010 | US7652040 Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists |